Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Ann Arbor, MI
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Minneapolis, MN
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Rochester, MN
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Kansas City, MO
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Omaha, NE
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Hackensack, NJ
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Morristown, NJ
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Morristown, NJ
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Paterson, NJ
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Paterson, NJ
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Albuquerque, NM
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Albany, NY
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Brooklyn, NY
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Buffalo, NY
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Mineola, NY
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
New York, NY
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Rochester, NY
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Chapel Hill, NC
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Akron, OH
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Columbus, OH
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Dayton, OH
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Portland, OR
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Danville, PA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Danville, PA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Erie, PA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Erie, PA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Hershey, PA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Hershey, PA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Pittsburgh, PA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Charleston, SC
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Columbia, SC
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Greer, SC
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Corpus Christi, TX
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Lackland, TX
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Lackland, TX
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Temple, TX
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Temple, TX
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Salt Lake City, UT
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Norfolk, VA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Spokane, WA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Morgantown, WV
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Morgantown, WV
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Madison, WI
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Mobile, AL
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Montgomery, AL
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Little Rock, AR
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Loma Linda, CA
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Sacramento, CA
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
San Diego, CA
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Denver, CO
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Englewood, CO
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Englewood, CO
Click here to add this to my saved trials
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
New Haven, CT
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials